Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to verify the superiority in efficacy (American College of
Rheumatology 20%: ACR20) and investigate the pharmacokinetics and safety of CDP870 versus
placebo without coadministration of MTX in active RA patients in whom MTX cannot be
administrated.